NET 1 UEPS TECHNOLOGIES INC (UEPS)

US64107N2062 - Common Stock

4.58  -0.14 (-2.97%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to UEPS. UEPS was compared to 86 industry peers in the IT Services industry. The financial health of UEPS is average, but there are quite some concerns on its profitability. UEPS is valied quite expensively at the moment, while it does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

UEPS had negative earnings in the past year.
The reported net income has been mixed in the past 5 years: UEPS reported negative net income in multiple years.
In multiple years UEPS reported negative operating cash flow during the last 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -9.24%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -27.72%
PM (TTM) -23.6%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for UEPS has been reduced compared to 1 year ago.
UEPS has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.72 indicates that UEPS is not a great score, but indicates only limited risk for bankruptcy at the moment.
There is no outstanding debt for UEPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.72
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

UEPS has a Current Ratio of 3.80. This indicates that UEPS is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 3.53 indicates that UEPS has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.8
Quick Ratio 3.53

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.25% over the past year.
Looking at the last year, UEPS shows a very strong growth in Revenue. The Revenue has grown by 38.99%.
UEPS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -26.03% yearly.
EPS 1Y (TTM)49.25%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q45.45%
Revenue 1Y (TTM)38.99%
Revenue growth 3Y-34.22%
Revenue growth 5Y-26.03%
Revenue growth Q2Q22.22%

3.2 Future

UEPS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.73% yearly.
Based on estimates for the next years, UEPS will show a very strong growth in Revenue. The Revenue will grow by 39.77% on average per year.
EPS Next Y-33.38%
EPS Next 2Y76.77%
EPS Next 3Y43.55%
EPS Next 5Y29.73%
Revenue Next Year21.86%
Revenue Next 2Y39.81%
Revenue Next 3Y39.32%
Revenue Next 5Y39.77%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

UEPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
UEPS is valuated reasonably with a Price/Forward Earnings ratio of 10.44.
The average S&P500 Price/Forward Earnings ratio is at 20.41. UEPS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 10.44

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2

4.3 Compensation for Growth

A more expensive valuation may be justified as UEPS's earnings are expected to grow with 43.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y76.77%
EPS Next 3Y43.55%

More info and screens

0

5. Dividend

5.1 Amount

UEPS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NET 1 UEPS TECHNOLOGIES INC

NASDAQ:UEPS (5/24/2022, 7:08:46 PM)

4.58

-0.14 (-2.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap271.04M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.44
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.24%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -27.72%
PM (TTM) -23.6%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.8
Quick Ratio 3.53
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)49.25%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-33.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)38.99%
Revenue growth 3Y-34.22%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y